Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

RLAY - Relay Therapeutics, Inc. Financial... | Finranks

Home

/

RLAY

R

Relay Therapeutics, Inc. (RLAY)

NGM – Real Time Price. Currency in USD

20.07

+0.08 (0.40%)

Market open: Aug 12, 2026, 10:44 AM EDT

20.17

+0.18 (0.90%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

15M

10M

26M

1M

Cost of goods sold

-4M

-5M

-5M

-4M

Gross Profit

12M

5M

20M

-3M

Operating expenses (excl. COGS)

-315M

-390M

-400M

-308M

Operating Income

-303M

-386M

-379M

-311M

Non-operating income, total

26M

48M

37M

20M

Pretax income

-276M

-338M

-342M

-291M

Equity in earnings

0

0

0

0

Taxes

0

0

0

0

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-276M

-338M

-342M

-291M

Discontinued operations

0

0

0

0

Net income

-276M

-338M

-342M

-291M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

621M-28.7%

871M+3.2%

844M-23.3%

1.10B

Total current assets

578M

809M

770M

1.02B

Total non-current assets

43M

62M

74M

80M

Total liabilities

54M-42.0%

94M+1.7%

92M-38.5%

150M

Total current liabilities

26M

51M

30M

64M

Total non-current liabilities

29M

43M

62M

86M

Total equity

567M

778M

752M

950M

Total liabilities & shareholders' equities

621M

871M

844M

1.10B

Total debt

32M-33.1%

49M-9.3%

53M-7.4%

58M

Name

2025

2024

2023

2022

Cash from operating activities

-235M

-249M

-300M

-229M

Cash from investing activities

193M

-41M

258M

-189M

Cash from financing activities

2M

270M

35M

290M

Free cash flow

-236M+6.1%

-251M+17.5%

-304M-27.6%

-239M